1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow KLU156: new trials by email Literature Review of KLU156 trials Research Report on KLU156
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria KLU156, Coartem - Uncomplicated Plasmodium Falciparum Malaria | Phase 3 | Completed | Novartis Pharmaceuticals | 1720 | 2024-03-07 | 2026-11-04 |
Malaria (1) · Malaria, Falciparum (1)
Burkina Faso (1) · Côte d’Ivoire (1) · Democratic Republic of the Congo (1) · Gabon (1) · Ghana (1) · Kenya (1) · Mali (1) · Niger (1) · Rwanda (1) · Tanzania (1) · Uganda (1) · Zambia (1)